Credit: Graphic created by M.E. Newman, Johns Hopkins Medicine, using public domain images, including SARS-CoV-2 virus particle courtesy of the National Institute of Allergy and Infectious Diseases
According to a new study by Johns Hopkins Medicine researchers, Paxlovid — a combination of two drugs — can safely be used to reduce the risk of severe COVID-19 from SARS-CoV-2 infection in a person who is pregnant.